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Abstract 
Tabernaemontana contorta Stapf, a flowering plant, belongs to the family Apocynaceae. In 
Cameroon, its leaves are used to prevent keloids formation and as antiseptic (Burkill, 1985). A 
new cerebroside, Contortamide (1) together with nine know compounds spegatrine (2), 
affinisine (3), Nb-methylaffinisine (4), ursolic acid (5), α-amyrin (6), bauerenol acetate (7), 
Lupeol (8), betulinic acid (9), β-sitosterolglycoside (10) were isolated from the bark of trunk of 
Tabernaemontana contorta Stapf. The new compound 1 showed significant activity against 
Caco-2 colon cancer cells with the MTT method. Compounds 1, 2, 3, 4, 6, 7, 8 and 9 were 
isolated for the first time from this species.  
Keywords: Contortamide; Tabernaemontana contorta Stapf; Apocynaceae; Colon 
Cancer. 
 
 
 
 
  
Figure S1.  HRESI-MS spectrum of compound 1. 
 
 
Figure S2. IR spectrum of compound 1. 
  
 
 
 Figure S3. 
1
H NMR spectrum (CD3OD, 400 MHz) of compound 1. 
 
Figure S4. COSY spectrum (CD3OD, 400 MHz) of compound 1. 
 Figure S5. 
13
C NMR spectrum (CD3OD, 100 MHz) of compound 1. 
 
Figure S6. DEPT 135 spectrum (CD3OD, 100 MHz) of compound 1. 
 
 Figure S7. HSQC spectrum (CD3OD, 400 MHz) of compound 1. 
 
Figure S8. HMBC spectrum (CD3OD, 400 MHz) of compound 1. 
 Figure S9. NOESY spectrum (CD3OD, 400 MHz) of compound 1. 
 
 
Figure S10. Selected HMBC (             ) and NOESY(                 ) correlations for compound 
1. 
 Figure S11.  ESI-MS Spectrum of compound 1. 
 
 
Figure S12. Mass fragmentation pattern of compound 1. 
 
Figure S13. Chemical structure of fatty acid (Methyl-2-hydroxypentacosanoate). 
 
 Figure S14.  ESI-MS of fatty acid (Methyl-2-hydroxypentacosanoate). 
 
 
 
 
  
                (a) Caco-2 cell line control               (b) Inhibition of Caco-2 cell line by TEM (1)                                        
Figure S15. Observation of Caco-2 cancer cells under a microscope. 
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Figure S16. A comparison of pure compounds, fraction, extract and standard drug 
actinomycin D growth inhibitory activities against Caco-2. All the results are represented as 
mean ± SD (n =3). 
 
Table S1. 
1
H (CD3OD, 400 MHz) and 
13
C (CD3OD, 100 MHz) NMR spectral data and 
HMBC correlations of compound 1. 
Position δH ppm (J in Hz) δC ppm HMBC (H→C) 
1H−1H COSY 
1a 4.02 (m) 68.5 C-1', C-1'' H-2 
1b 3.79 (dd, 7.2; 14.8) 68.5 C-1', C-1'', C-3 H-2 
2 4.24 (m) 50.3 C-1 H-1, H-3 
3 3.57 (t,  6.1) 74.4 C-2, C-4, C-5 H-2, H-4 
4 3.50 (m) 71.4 - H-3, H-5 
5a 1.98 (m) 32.4 C-6, C-7 H-4 
5b 2.01 (m) 32.4 C-6, C-7 H-4 
6 5.40 (dt)  129.4 C-5 H-5 
7 5.36  (dt) 130.4 C-8 H-8 
8 1.64 (m) 32.0 C-7 H-7 
9 - 16 1.28-1.40 (brs) 22.2-
31.7 
 H-8 
17 0.89 (t,  6.7) 13.1 C-16 H-17 
1'  176.2 -  
2' 4.00 (m) 71,5 C-1', C-3' H-3' 
3'a 1.73 (m) 34.4 C-2' H-2' 
3'b 1.63 (m) 34.4 C-2' H-4' 
4' – 24' 1.28-1.40 (brs) 22.2-
31.7 
 H-5' 
25' 0.89 (t, 6.7) 13.1 C-25' H-25' 
Glucose     
1'' 4.26 (d, 7.8) 103.3 C-1, C-2'', C-3'' H-2'' 
2'' 3.16 (dd, 8; 16.8) 73.6 C-1, C-3'' H-1'', H-3'' 
3'' 3.33 (m) 76.5 C-4'' H-2'', H-4'' 
4'' 3.26 (dd, 4;12.3;)  70.2 C-3'', C-5'' H-3'', H-5'' 
5'' 3.27 (m) 76.6 C-3'' H-4'', H-6'' 
6''a 3.85 (dd, J = 11,2) 61.3 C-5'' H-5'' 
6''b 3.64 (dd, J = 4.4; 11.2) 61.3 C-5'' H-5'' 
 
 
